How would you approach therapy for a patient with symptomatic secondary CNS marginal zone lymphoma, but with low-volume systemic disease that would otherwise not warrant therapy?   

Would your approach differ for a 30 year old and a 70 year old?



Answer from: Medical Oncologist at Academic Institution

Answer from: at Community Practice

Answer from: Medical Oncologist at Academic Institution